Also, we explored the expression of SIGLEC-5 and VISTA as ligands in monocytes from patients with OSA and control subjects and investigated the regulatory role of intermittent hypoxia on the PSGL-1 axis using different in vitro models. Here, SIGLEC5 is linked to obstructive sleep apnea syndrome.